KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Cash from Investing Activities (2019 - 2025)

Historic Cash from Investing Activities for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to -$18.0 million.

  • GoodRx Holdings' Cash from Investing Activities fell 1349.39% to -$18.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$104.8 million, marking a year-over-year decrease of 5746.75%. This contributed to the annual value of -$70.3 million for FY2024, which is 2614.68% down from last year.
  • GoodRx Holdings' Cash from Investing Activities amounted to -$18.0 million in Q3 2025, which was down 1349.39% from -$18.3 million recorded in Q2 2025.
  • GoodRx Holdings' 5-year Cash from Investing Activities high stood at $1.3 million for Q4 2022, and its period low was -$163.6 million during Q2 2022.
  • Over the past 5 years, GoodRx Holdings' median Cash from Investing Activities value was -$16.6 million (recorded in 2024), while the average stood at -$31.8 million.
  • In the last 5 years, GoodRx Holdings' Cash from Investing Activities plummeted by 260197.48% in 2021 and then soared by 11388.92% in 2022.
  • GoodRx Holdings' Cash from Investing Activities (Quarter) stood at -$9.3 million in 2021, then surged by 113.89% to $1.3 million in 2022, then crashed by 1100.93% to -$12.9 million in 2023, then dropped by 29.3% to -$16.6 million in 2024, then decreased by 8.14% to -$18.0 million in 2025.
  • Its last three reported values are -$18.0 million in Q3 2025, -$18.3 million for Q2 2025, and -$51.9 million during Q1 2025.